AGER and chronic obstructive pulmonary disease: In addition, CSE‐treated cells activate Nuclear factor erythroid2‐related factor 2 (Nrf2) to change the distribution and expression of RAGE, and then through MAPK and NF‐κB to induce redox‐sensitive DAMPs74 (Table 2), thereby participating in COPD complications.